112 related articles for article (PubMed ID: 26083966)
1. Amino Acid-Dependent Attenuation of Toll-like Receptor Signaling by Peptide-Gold Nanoparticle Hybrids.
Yang H; Fung SY; Xu S; Sutherland DP; Kollmann TR; Liu M; Turvey SE
ACS Nano; 2015 Jul; 9(7):6774-84. PubMed ID: 26083966
[TBL] [Abstract][Full Text] [Related]
2. Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells.
Yang H; Kozicky L; Saferali A; Fung SY; Afacan N; Cai B; Falsafi R; Gill E; Liu M; Kollmann TR; Hancock RE; Sly LM; Turvey SE
Biomaterials; 2016 Dec; 111():90-102. PubMed ID: 27728817
[TBL] [Abstract][Full Text] [Related]
3. Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling.
Yang H; Fung SY; Bao A; Li Q; Turvey SE
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28784964
[TBL] [Abstract][Full Text] [Related]
4. Size-dependent anti-inflammatory activity of a peptide-gold nanoparticle hybrid in vitro and in a mouse model of acute lung injury.
Gao W; Wang Y; Xiong Y; Sun L; Wang L; Wang K; Lu HY; Bao A; Turvey SE; Li Q; Yang H
Acta Biomater; 2019 Feb; 85():203-217. PubMed ID: 30597258
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Anti-inflammatory Activity of Peptide-Gold Nanoparticle Hybrids upon Cigarette Smoke Extract Modification through TLR Inhibition and Autophagy Induction.
Gao W; Wang L; Wang K; Sun L; Rao Y; Ma A; Zhang M; Li Q; Yang H
ACS Appl Mater Interfaces; 2019 Sep; 11(36):32706-32719. PubMed ID: 31411854
[TBL] [Abstract][Full Text] [Related]
6. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
7. The Modulatory Activity of Tryptophan Displaying Nanodevices on Macrophage Activation for Preventing Acute Lung Injury.
Sun L; Wang R; Wu C; Gong J; Ma H; Fung SY; Yang H
Front Immunol; 2021; 12():750128. PubMed ID: 34659253
[TBL] [Abstract][Full Text] [Related]
8. Peptide-Gold Nanoparticle Hybrids as Promising Anti-Inflammatory Nanotherapeutics for Acute Lung Injury: In Vivo Efficacy, Biodistribution, and Clearance.
Xiong Y; Gao W; Xia F; Sun Y; Sun L; Wang L; Ben S; Turvey SE; Yang H; Li Q
Adv Healthc Mater; 2018 Oct; 7(19):e1800510. PubMed ID: 30101578
[TBL] [Abstract][Full Text] [Related]
9. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway.
Bhaskar S; Shalini V; Helen A
Immunobiology; 2011 Mar; 216(3):367-73. PubMed ID: 20828867
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.
Lee JK; Kim SY; Kim YS; Lee WH; Hwang DH; Lee JY
Biochem Pharmacol; 2009 Apr; 77(8):1391-400. PubMed ID: 19426678
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
12. Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages.
Chino A; Sakurai H; Choo MK; Koizumi K; Shimada Y; Terasawa K; Saiki I
Int Immunopharmacol; 2005 May; 5(5):871-82. PubMed ID: 15778123
[TBL] [Abstract][Full Text] [Related]
13. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
Lee SM; Kim EJ; Suk K; Lee WH
J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
[TBL] [Abstract][Full Text] [Related]
14. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
15. Suppression of TRIF-dependent signaling pathway of toll-like receptors by (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine.
Gu GJ; Eom SH; Suh CW; Koh KO; Kim DY; Youn HS
Eur J Pharmacol; 2013 Dec; 721(1-3):109-15. PubMed ID: 24080550
[TBL] [Abstract][Full Text] [Related]
16. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
17. A gold nanocluster/MIL-100(Fe) bimodal nanovector for the therapy of inflammatory disease through attenuation of Toll-like receptor signaling.
Zhao H; Becharef S; Dumas E; Carn F; Patriarche G; Mura S; Gazeau F; Serre C; Steunou N
Nanoscale; 2024 Jun; 16(25):12037-12049. PubMed ID: 38809107
[TBL] [Abstract][Full Text] [Related]
18. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
Gringhuis SI; den Dunnen J; Litjens M; van Het Hof B; van Kooyk Y; Geijtenbeek TB
Immunity; 2007 May; 26(5):605-16. PubMed ID: 17462920
[TBL] [Abstract][Full Text] [Related]
19. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
Park SJ; Lee AN; Youn HS
Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
